High serum pancreatic secretory trypsin inhibitor before onset of type ii citrullinemia

Neurology

Volumn 57, Issue 5, 2001, Pages 933-

  Tsuboi, Yoshio ^a   Fujino, Y ^b   Kobayashi, K ^c   Saheki, T ^c   Yamada, T ^b  

^a MAYO CLINIC   (United States)

^b FUKUOKA UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; APROTININ; ARGININOSUCCINATE SYNTHASE; SECRETORY PROTEIN;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CITRULLINEMIA; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 0035845608     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.5.933     Document Type: Article

References (7)

1. Hereditary disorders of the urea cycle in man: Biochemical and molecular approaches
2. Type II citrullinemia (citrin deficiency): A mysterious disease caused by a defect of calcium-binding mitochondrial carrier protein
3. The gene mutated in adult-onset type II citrullinemia encodes a putative mitochondrial carrier protein
4. Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia
5. Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia
6. Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair
7. Liver transplantation in type II citrullinemia